Patent details

EP2552906 Title: CGRP RECEPTOR ANTAGONIST

Basic Information

Publication number:
EP2552906
PCT Application Number:
PCT/US/2011/028168
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP117100875
PCT Publication Number:
WO/2011/123232
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CGRP RECEPTOR ANTAGONIST
French Title of Invention:
ANTAGONISTE DES RÉCEPTEURS CGRP
German Title of Invention:
CGRP-REZEPTORANTAGONISTEN
SPC Number:

Dates

Filing date:
11/03/2011
Grant date:
06/01/2016
EP Publication Date:
06/01/2016
PCT Publication Date:
06/10/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/02/2013
EP B1 Publication Date:
06/01/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
11/03/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/03/2011
 
 

Name:
Bristol-Myers Squibb Company
Address:
Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
21/01/2016
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
DUBOWCHIK Gene M.
Address:
United States (US)

2

Name:
CHATURVEDULA Prasad V.
Address:
United States (US)

3

Name:
MACOR John E.
Address:
United States (US)

Priority

Priority Number:
319015 P
Priority Date:
30/03/2010
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 401/14;

Annual Fees

Annual Fee Due Date:
31/03/2026
Annual Fee Number:
16
Annual Fee Amount:
230 Euro
Expected Payer:
Last Annual Fee Payment Date:
12/02/2025
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
213 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56